Earnings Call Summary | Arcadia Biosciences(RKDA.US) Q2 2024 Earnings Conference
Earnings Call Summary | Arcadia Biosciences(RKDA.US) Q2 2024 Earnings Conference
Selling, general and administrative costs were $2.7 million, up by $600,000 both from Q1 2024 and Q2 2023, primarily due to M&A related expenses.The following is a summary of the Arcadia Biosciences, Inc. (RKDA) Q2 2024 Earnings Call Transcript:
以下是阿凱迪亞生物科學公司（RKDA）2024年第二季度業績會成績摘要：
Financial Performance:
金融業績：
Q2 total revenues were approximately $1.3 million, a 32% sequential increase but flat year-over-year.
Q2 gross profit was $673,000, marking a 30% increase from last quarter and up 4% year-over-year, with a gross margin of 52%.
Selling, general and administrative costs were $2.7 million, up by $600,000 both from Q1 2024 and Q2 2023, primarily due to M&A related expenses.
Net cash consumption expected to halve in 2024 compared to $15 million the previous year.
2024年第二季度總營業收入約爲130萬美元，較上一季度增長了32％，但與去年同期持平。
第二季度毛利潤爲673,000美元，較上一季度增長30％，較去年同期增長4％，毛利率爲52％。
銷售和一般管理費用爲270萬美元，分別比2024年第一季度和2023年第二季度增加了60萬美元，主要是由於併購相關費用。
預計2024年的淨現金消耗將比上一年減少一半，即1500萬美元。
Business Progress:
業務進展：
Monetized part of wheat IP, resulting in $4 million cash from asset sale to Corteva and a $6 million promissory note from the sale of GoodWheat assets to Above Food.
Achieved significant headcount reductions and facility exit leading to estimated annual savings of $2 million.
Strong growth and expanded distribution for Zola Coconut Water, with a notable 42% sales increase in Q2.
Initiated shipping of new Zola flavors: original, lime, and pineapple.
以小麥知識產權的一部分爲代價，向Corteva出售資產可獲得400萬美元，向Above Food出售GoodWheat資產的出售承諾爲600萬美元。
大幅減少員工人數和設施退出，預計每年可節省200萬美元。
Zola椰子水的增長和擴大分銷渠道表現強勁，在2024年第二季度銷售額顯着增長42％。
開始發貨新的Zola口味：原味、青檸和菠蘿。
Opportunities:
機會：
New distribution gains for Zola expected to offset lost sales from discontinued GoodWheat operations, aiming for revenue alignment with 2023 figures.
預計Zola的新分銷可以抵消因GoodWheat業務停止而失去的銷售額，旨在將收入與2023年數字保持一致。
Risks:
風險：
Continued declines in GLA oil revenues expected as remaining inventory is sold off through the end of 2024.
Potential risks in sustaining profitability if market share or growth in the coconut water segment does not meet expectations.
隨着剩餘庫存銷售至2024年底，預計GLA油營收將持續下降。
如果椰子水市場份額或增長未達到預期，將存在維持盈利能力的潛在風險。
More details: Arcadia Biosciences IR
更多詳情：阿凱迪亞生物科學公司IR
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：如需更全面的詳情，請參閱投資人關係網站。本文僅供投資者參考，不作任何指引或建議。
譯文內容由第三人軟體翻譯。
